Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2019 17:30 ET | Source: vTv Therapeutics Inc.

vTv Therapeutics Announces 2019 Third Quarter Financial Results and Update

SimpliciT-1 Study of TTP399 in patients with type 1 diabetes fully-enrolled Elevage Study of azeliragon in patients with mild Alzheimer’s disease with type 2 diabetes actively enrolling HIGH POINT,...
October 03, 2019 07:30 ET | Source: vTv Therapeutics Inc.

vTv to Host Key Opinion Leader Event to Discuss the Type 1 Diabetes Treatment Landscape and Emerging Therapies as Adjuncts to Insulin

HIGH POINT, N.C., Oct. 03, 2019 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), today announced that the Company will host a key opinion leader (KOL) presentation and webcast discussing...
September 18, 2019 07:30 ET | Source: vTv Therapeutics Inc.

vTv Therapeutics Presents Additional Positive Data from the Phase 2 Simplici-T1 Study in Patients with Type 1 Diabetes at 55th Annual Meeting of the European Association for the Study of Diabetes

HIGH POINT, N.C., Sept. 18, 2019 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), today presented additional positive data from its phase 2 Simplici-T1 study in patients with type 1...
September 11, 2019 07:30 ET | Source: vTv Therapeutics Inc.

vTv Therapeutics to Present Posters at Two Scientific Conferences in September

Presenting New Clinical Data from Phase 2 Study in Type 1 Diabetes with Liver Selective GKA Program Pre-Clinical Data in NASH with the NRF2/Bach1 Program HIGH POINT, N.C., Sept. 11, 2019 (GLOBE...
September 04, 2019 07:30 ET | Source: vTv Therapeutics Inc.

vTv Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference

HIGH POINT, N.C., Sept. 04, 2019 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for...
August 06, 2019 16:05 ET | Source: vTv Therapeutics Inc.

vTv Therapeutics to Participate in Upcoming Canaccord Genuity and Solebury Trout Conferences

HIGH POINT, N.C., Aug. 06, 2019 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered...
July 31, 2019 16:30 ET | Source: vTv Therapeutics Inc.

vTv Therapeutics Announces 2019 Second Quarter Financial Results and Update

HIGH POINT, N.C., July 31, 2019 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the second quarter that ended June 30, 2019, and provided an update on...